Related Experiment Video
Updated: May 10, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Optimal allocation of sample sizes to multicenter clinical trials.
Dejian Lai1, Kuang-Chao Chang, Mohammad H Rahbar
1Division of Biostatistics, University of Texas School of Public Health, Houston, TX 77030, USA. Dejian.lai@uth.tmc.edu
This study presents a method for optimal sample size allocation in multicenter clinical trials, considering treatment costs, patient availability, and endpoint variability. The approach, adapted from stratified sampling, aims to improve trial design efficiency.
Area of Science:
- Clinical Trials
- Biostatistics
- Health Services Research
Background:
- Designing multicenter clinical trials requires careful consideration of resource allocation.
- Optimal sample size determination is crucial for trial efficiency and statistical power.
Purpose of the Study:
- To introduce and evaluate an approach for optimal sample size allocation in multicenter clinical trials.
- To adapt a stratified sampling survey design for efficient sample size determination across trial centers.
Main Methods:
- The proposed method allocates sample sizes based on center-specific treatment costs, endpoint standard deviation, and patient availability.
- The approach was adapted from established stratified sampling survey designs.
- Hypothetical scenarios and simulation studies were used to illustrate and assess the method.
Main Results:
- The approach provides a framework for optimizing sample size distribution in multicenter trials.
- Simulation results demonstrate the practical application and potential benefits of the proposed allocation method.
- The method integrates key factors influencing sample size decisions in complex trial settings.
Conclusions:
- The discussed approach offers a systematic way to determine optimal sample size allocation in multicenter clinical trials.
- This method can enhance the efficiency and cost-effectiveness of clinical trial design.
- Further application and validation in diverse trial settings are warranted.
More Related Videos
06:55Inverse Probability of Treatment Weighting (Propensity Score) using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
08:01Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Clinical Trials
There are four phases in a clinical trial. A phase one...
Sample Size Calculation
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
Bioavailability Study Design: Single Versus Multiple Dose Studies
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs